Charles River Laboratories International, Inc. (NYSE:CRL) Sees Significant Increase in Short Interest

NodeGuardian · 2026-04-05T14:57:05+00:00

Short interest in Charles River Laboratories rose 19.8% in February to 3,537,661 shares. Despite surpassing earnings estimates, revenue declined year-over-year. Analysts maintain a "Moderate Buy" rating with a price target of $203.57.

NodeGuardian

2026-04-05 14:57:05

Abstract generation in progress

Short interest in Charles River Laboratories International (NYSE:CRL) surged by 19.8% in February, reaching 3,537,661 shares, which represents about 7.3% of its shares sold short. Despite slightly beating quarterly earnings and revenue estimates, the company’s revenue was down year-over-year, and it provided full-year 2026 EPS guidance. Analysts currently have a “Moderate Buy” consensus rating for CRL with an average price target of $203.57.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.